Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Fetzima price, strengths & recalls

Brand of levomilnacipran (generic)

Pharmacies pay $527.63 for 30 capsules of Fetzima 120 mg (24 hr) extended-release capsule this week, and from $17.61 to $528.13 across its 5 priced strengths and forms. Its official label last changed on February 23, 2026.

Brand
Pharmacies pay$527.63for 30 capsules of 120 mg (24 hr) extended-release capsuleNo change in 4 weeks
Fair cash price
$617.27
Strengths
5
Makers
1
Updated
Nov 11

Fetzima price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
20 mg (24 hr) extended-release capsule Brand$17.60$528.09 / 30 capsulesNo change+5.0%
40 mg (24 hr) extended-release capsule Brand$17.60$528.13 / 30 capsulesNo change+4.8%
80 mg (24 hr) extended-release capsule Brand$17.59$527.62 / 30 capsulesNo change+4.7%
120 mg (24 hr) extended-release capsule Brand$17.59$527.63 / 30 capsulesNo change+4.8%
Fetzima pack Brand$17.61$17.61 / 1 kitNo change+5.0%

The lowest cost per capsule is 80 mg (24 hr) extended-release capsule at $17.59. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Fetzima vs generic levomilnacipran

There is no generic version of Fetzima on the market yet. Its last listed patent or exclusivity runs to May 23, 2032 - generics often follow, though court cases and settlements can move the date either way.

GenericLevomilnacipran prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 15, 2026
No ongoing recallsNone on record

What did you pay for fetzima? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedFebruary 23, 2026
Version33 of 23
EffectiveApr 30, 2024
Read the label

These highlights do not include all the information needed to use FETZIMA safely and effectively. See full prescribing information for FETZIMA. FETZIMA® (levomilnacipran) extended-release capsules, for oral use Initial U.S. Approval: 2009 (milnacipran)

This drug has a boxed warning

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.1)].

FETZIMA is not approved for use in pediatric patients [see Use in Specific Populations (8.4)].

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors (5.1). FETZIMA is not approved for use in pediatric patients (8.4).

Recent major changes (as listed on the label)

Warnings and Precautions (5.2, 5.5) | 8/2023 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA204168 · Abbvie
First approved
July 25, 2013 (13 years ago)
Latest approved change
April 19, 2024
Approved label
PDF, Apr 24, 2024
Generic makers
None on the market
Last patent listed
May 23, 2032
Exclusivity ends
March 24, 2026 (ended)

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Fetzima questions

How much does fetzima cost without insurance?

Pharmacies pay about $527.63 for 30 capsules of fetzima 120 mg (24 hr) extended-release capsule ($17.59 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $617.27. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Fetzima?

Yes: levomilnacipran. Compare levomilnacipran prices.

Is fetzima in shortage?

No shortage is reported for fetzima right now. We check the national shortage list every day.

Has fetzima been recalled?

No recalls are on record for fetzima.

When did the fetzima label last change?

The official label was last updated on February 23, 2026 (version 33). See what changed.

Talk about fetzima

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.